A modified Bilirubin-induced neurologic dysfunction (BIND-M) algorithm is useful in evaluating severity of jaundice in a resource-limited setting

BMC Pediatrics

Volumn 15, Issue 1, 2015, Pages

  Radmacher, Paula G ^a   Groves, Frank D ^b   Owa, Joshua A ^c   Ofovwe, Gabriel E ^d   Amuabunos, Emmanuel A ^d   Olusanya, Bolajoko O ^e   Slusher, Tina M ^f,g  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^d UNIVERSITY OF BENIN   (Nigeria)

^e Healthy Start Initiative   (Nigeria)

^f UNIVERSITY OF MINNESOTA   (United States)

^g HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Acute bilirubin encephalopathy; Evaluation of BIND score; Severe neonatal jaundice

Indexed keywords

BILIRUBIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

ARTICLE; ASSESSMENT OF HUMANS; CONSULTATION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; INFANT; INTERRATER RELIABILITY; KAPPA STATISTICS; KERNICTERUS; MAJOR CLINICAL STUDY; MALE; MODIFIED BILIRUBIN INDUCED NEUROLOGIC DYSFUNCTION SCORE; NEWBORN JAUNDICE; NIGERIAN; PEDIATRICIAN; PHENOTYPE; PREDICTIVE VALUE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; ALGORITHM; CLINICAL COMPETENCE; COMPLICATION; DEVELOPING COUNTRY; MEDICAL EDUCATION; NIGERIA; PATIENT ACUITY; PEDIATRICS; REPRODUCIBILITY;

ALGORITHMS; CLINICAL COMPETENCE; DEVELOPING COUNTRIES; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; INTERNSHIP AND RESIDENCY; JAUNDICE, NEONATAL; KERNICTERUS; NIGERIA; PATIENT ACUITY; PEDIATRICS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84926376491     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/s12887-015-0355-2     Document Type: Article

References (18)

1. Tomashek KM, Crouse CJ, Iyasu S, Johnson CH, Flowers LM. A comparison of morbidity rates attributable to conditions originating in the perinatal period among newborns discharged from United States hospitals, 1989-90 and 1999-2000. Paediatr Perinat Epidemiol. 2006;20:24-34.
2. Escobar GJ, Greene JD, Hulac P, Kincannon E, Bischoff K, Gardner MN, et al. Rehospitalisation after birth hospitalisation: patterns among infants of all gestations. Arch Dis Child. 2005;90:125-31.
3. The Young Infants Clinical Signs Study Group. Clinical signs that predict severe illness in children under age 2 months: a multicentre study. Lancet. 2008;371:135-42.
4. National Institute for Health and Clinical Excellence. Neonatal jaundice. (Clinical guideline 98) 2010. www.nice.org.uk/CG98.
5. Ip S, Chung M, Kulig J, O'Brien R, Sege R, Glicken S, et al. American academy of pediatrics subcommittee on hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004;114:e130-53.
6. Slusher TM, Olusanya BO. Neonatal jaundice in low- and middle-income countries. In: Stevenson DK, Maisels J, Watchko J, editors. Care of the jaundiced neonate. New York, NY: McGraw-Hill; 2012. p. 263-73.
7. Owa JA, Ogunlesi TA. Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World J Pediatr. 2009;5:51-5.
8. Ogunlesi TA, Adekanmbi AF, Fetuga MB, Ogunfowora OB. The incidence and outcome of bilirubin encephalopathy in Nigeria: a bi-centre study. Niger J Med. 2007;16:354-9.
9. Ogunfowora OB, Daniel OJ. Neonatal jaundice and its management: knowledge, attitude and practice of community health workers in Nigeria. BMC Public Health. 2006;6:19-23.
10. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol. 2009;29 Suppl 1:S25-45.
11. Smitherman H, Stark AR, Bhutani VK. Early recognition of neonatal hyperbilirubinemia and its emergent management. Semin Fetal Neonatal Med. 2006;11:214-24.
12. Johnson LH, Brown AK, Bhutani VK. BIND - a clinical score for bilirubin-induced neurologic dysfunction in newborns. Pediatrics. 1999;199(3 part 3):746-7.
13. Shapiro SM. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol. 2005;25:54-9.
14. Davutoğlu M, Garipardiç M, Güler E, Karabiber H, Erhan D. The etiology of severe neonatal hyperbilirubinemia and complications of exchange transfusion. Turk J Pediatr. 2010;52:163-6.
15. Behjati SH, Sagheb S, Aryasepehr S, Yaghmai B. Adverse events associated with neonatal exchange transfusion for hyperbilirubinemia. Indian J Pediatr. 2009;76:83-5.
16. Olowe SA, Ransome-Kuti O. The risk of jaundice in glucose-6-phosphate dehydrogenase deficient babies exposed to menthol. Acta Paediatr Scand. 1980;69:341-5.
17. Owa JA. The relationship between exposure to icterogenic agents, glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Nigeria. Acta Paediatr Scand. 1989;78:848-52.
18. Dawodu AH, Owa JA, Familusi JB. A prospective study of the role of bacterial infections and G-6-Pd deficiency in severe neonatal jaundice in Nigeria. Trop Geogr Med. 1984;36:127-32.